Pedone Claudio, Costanzo Luisa, Cesari Matteo, Bandinelli Stefania, Ferrucci Luigi, Antonelli Incalzi Raffaele
Area di Geriatria, Università Campus Biomedico, Roma, Italy.
Institut du Vieillissement. Université de Toulouse, Toulouse, France.
J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):84-9. doi: 10.1093/gerona/glv096. Epub 2015 Aug 13.
The frailty phenotype (FP) proposed by Fried and colleagues (Fried LP, Tangen CM, Walston J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.) requires the administration of performance tests (gait speed, handgrip strength) not always feasible in routine clinical practice. Furthermore, the discriminative capacity of the instrument has been rarely investigated. Aim of this study was to evaluate the discriminative capacity of the FP and compare it with a modified version including only anamnestic information.
Data are from 890 participants of the InCHIANTI study without impairment in activities of daily living (ADL) at baseline (mean age 74 years, women 55%). Frailty was defined by (a) the presence of ≥ 3 criteria of the FP, and (b) having ≥ 2 criteria of an anamnestic FP (AFP), not including gait speed and handgrip strength. Sensitivity, specificity, positive and negative predictive values (PPV, NPV) were used to evaluate the discriminative capacity of both definitions for incident disability (ie, loss of at least one ADL), incidence of "accelerated" disability (loss of >2 ADL) over a 6-year follow-up, and 5-years mortality.
FP and AFP yielded a frailty prevalence of 6.4% and 6.5%, respectively; only 32 patients were considered frail by both indices (kappa: .53). For incident disability, FP showed sensitivity = .194, specificity = .963, PPV = .400, and NPV = .903. Similarly, AFP had sensitivity = .129, specificity = .949, PPV = .245, and NPV = .894. Consistent results were found for accelerated disability and mortality.
In our sample, both FP and AFP showed low sensitivity in identifying older people who would die or develop disability, but they could well discriminate people who would not experience adverse outcomes.
Fried及其同事提出的衰弱表型(FP)(Fried LP,Tangen CM,Walston J等;心血管健康研究协作研究组。老年人的衰弱:一种表型的证据。《老年学杂志A:生物科学与医学科学》。2001年;56:M146 - M156。)需要进行体能测试(步速、握力),而这在常规临床实践中并不总是可行的。此外,该工具的鉴别能力很少被研究。本研究的目的是评估FP的鉴别能力,并将其与仅包含问诊信息的修改版本进行比较。
数据来自于基期日常生活活动(ADL)无损伤的890名InCHIANTI研究参与者(平均年龄74岁,女性占55%)。衰弱定义为:(a)存在≥3项FP标准,以及(b)具有≥2项问诊衰弱表型(AFP)标准,不包括步速和握力。敏感性、特异性、阳性和阴性预测值(PPV、NPV)用于评估这两种定义对新发残疾(即至少一项ADL丧失)、6年随访期间“加速”残疾(>2项ADL丧失)发生率以及5年死亡率的鉴别能力。
FP和AFP的衰弱患病率分别为6.4%和6.5%;只有32名患者被两个指标都判定为衰弱(kappa值:0.53)。对于新发残疾,FP的敏感性 = 0.194,特异性 = 0.963,PPV = 0.400,NPV = 0.903。同样,AFP的敏感性 = 0.129,特异性 = 0.949,PPV = 0.245,NPV = 0.89。在加速残疾和死亡率方面也得到了一致的结果。
在我们的样本中,FP和AFP在识别会死亡或出现残疾的老年人方面敏感性都较低,但它们能够很好地区分不会经历不良结局的人群。